UF Health Cancer Center

Name

UF Health Cancer Center

Legal name

University of Florida Health Cancer Center

Website

https://cancer.ufl.edu

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Cancer Treatment Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Research and Development in the Physical, Engineering, and Life Sciences (54171), Colleges, Universities, and Professional Schools (6113), Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industry

Public Research Universities with Academic Medical Centers (AMCs) (EDAHAAAC)

Keywords

• Cancer treatment services
• Clinical trial research
• Oncology patient care
• Academic cancer center
• Cancer screening programs

Headquarters

HQ city

Gainesville

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Clinical Care Revenue: Revenue from patient care services provided at UF Health Shands Cancer Hospital, UF Health Davis Cancer Pavilion, and UF Health Shands Children's Hospital. Services covered by insurance, Medicare, Medicaid, and self-pay.
2. Research Grants and Funding: Federal research funding primarily from NIH/NCI, foundation grants, and institutional funding supporting cancer research programs and clinical trials
3. Cancer Center Support Grant: NCI-designated cancer center support grant (P30) providing core funding for research infrastructure and shared resources
4. Philanthropic Giving: Donations from individuals, corporations, and foundations to support cancer research, patient care, and facilities

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

UF Health Cancer Center is an NCI-designated academic cancer center providing comprehensive cancer prevention, early diagnosis, treatment, and survivorship services to patients in North Central Florida. It operates four research programs (Cancer Control and Population Sciences; Cancer Targeting and Therapeutics; Mechanisms of Oncogenesis; Immuno-Oncology and Microbiome) and runs roughly 175–300 active clinical trials, alongside inpatient and outpatient oncology care at UF Health Shands Cancer Hospital, UF Health Davis Cancer Pavilion, and UF Health Shands Children's Hospital.

Product overview

UF Health Cancer Institute is an NCI-designated cancer center offering a comprehensive portfolio of cancer research and clinical services. The institute operates through its core clinical care and research programs, supported by the NaviGATOR clinical trial search platform, the Mobile Cancer Screening Connector for community outreach, and the Clinical Research Office managing trials. Research infrastructure includes four research programs (Cancer Control and Population Sciences, Cancer Targeting and Therapeutics, Mechanisms of Oncogenesis, Immuno-Oncology and Microbiome), specialized working groups, and shared resources for biostatistics, sequencing, cytometry, and bioinformatics. The Data Alignment Assessment Tool (DAAT) is an internal quality improvement tool for clinical trial design optimization.

Differentiator

Problem solved

Functional benefit

Products and services

• UF Health Cancer Institute NCI-designated cancer center providing comprehensive cancer research, prevention, detection, and treatment services; supports over 350 researchers from all 16 University of Florida colleges across 75 departments.
• Mobile Cancer Screening Connector

Quantifiable outcome

• 43% increase in annual budget for cancer research activities since 2022
• +3 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Eight partnerships are on record, tiered core.

• Moffitt Cancer CentercoreStrategic or Co-development Partner · 7 May 2024Collaboration on $3.4 million NCI grant to study PROTAC drug enhancing immunotherapy treatments for melanoma patients in Florida.
• Sylvester Comprehensive Cancer CentercoreStrategic or Co-development Partner · 1 June 2023Partnership in the ASCENT (Adding Social Context to Advance Cancer Survivorship) study funded by Florida Department of Health Innovation Grant, aiming to improve nutrition in cancer care and enhance survivors' quality of life.
• The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & TechnologycoreStrategic or Co-development PartnerResearch partnership combining robot-assisted drug screening technology with pharmacogenomics research at UF. Part of expanded research programs.
• NRG OncologycoreStrategic or Co-development PartnerClinical trials network partnership with 5 NRG affiliate sites within Florida. Thomas George serves as co-chair of NRG Oncology GI Committee and site principal investigator for NCI's Experimental Therapeutics Clinical Trials Network.
• OneFlorida+ Clinical Research NetworkcoreStrategic or Co-development PartnerStatewide clinical research network enhancing access to cancer clinical trials throughout Florida through ARC Network.
• Florida-California Cancer Research, Education and Engagement (CaRE2) Health CentercoreStrategic or Co-development PartnerMulti-institutional partnership focused on cancer research, education, and engagement to address health equity.
• Community-Partnered Cancer Disparities Research Collaborative (CDRC)coreStrategic or Co-development PartnerCommunity-partnered research initiative to reduce burden of cancer through promoting cancer prevention, treatment, and survivorship in partnership with community stakeholders.
• UF Health Cancer Center Academic Research Consortium (ARC)coreStrategic or Co-development PartnerStatewide network retreat bringing together clinical research partners from across Florida for education, networking, and collaboration on cancer research.

Scale indicators14 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Roswell Park Comprehensive Cancer Center: NCI-designated comprehensive cancer center with an integrated clinical and research model covering basic, translational, clinical, and population sciences. Comparable in scope, academic affiliation model, and post-NCI-designation growth profile.
• Vanderbilt-Ingram Cancer Center: NCI-designated comprehensive cancer center at a major research university with a closely aligned portfolio: investigator-initiated clinical trials, basic-translational-population science programs, and community catchment across a multi-state region. Similar academic structure and research output scale.
• Fred Hutchinson Cancer Center: NCI-designated comprehensive cancer center with a research-intensive model emphasizing translational science, clinical trials, and population sciences. Highly comparable in academic cancer center mission and university affiliation structure.
• Winship Cancer Institute of Emory University: NCI-designated cancer center at a major public-adjacent research university with a comparable model: deep clinical trials portfolio, community outreach, population sciences focus, and university-wide faculty engagement. Closely matched in size, scope, and stage of NCI-designated growth.
• Duke Cancer Institute: NCI-designated cancer center integrated within a leading academic medical center, offering comprehensive oncology clinical care, translational research, and population sciences. Highly comparable in academic cancer center model and clinical trials volume.
• Sylvester Comprehensive Cancer Center: NCI-designated cancer center at the University of Miami, the third NCI cancer center in Florida. It shares UF Health Cancer Institute's public-university academic model, comprehensive research portfolio, and large clinical trials operation, including direct partnership on the ASCENT survivorship study.
• Moffitt Cancer Center: Another NCI-designated cancer center in Florida with a similar academic medical center affiliation, comprehensive cancer research and clinical care mission, and overlapping disease site focus. Moffitt is the most direct competitor in the state for patients, talent, and federal funding.

Broad incumbents

• Memorial Sloan Kettering Cancer Center: Premier NCI-designated comprehensive cancer center with deep clinical trials portfolio, translational research, and proprietary technology platforms. Comparable as a comprehensive cancer center, but at substantially greater scale and with national/international reach.
• Mayo Clinic Comprehensive Cancer Center: NCI-designated comprehensive cancer center and a much larger, nationally recognized integrated cancer care and research enterprise. Comparable as an academic cancer center of similar mission scope, with substantially greater scale and national reach.
• University of Texas MD Anderson Cancer Center: The largest NCI-designated comprehensive cancer center in the U.S., focused exclusively on cancer patient care, research, education, and prevention. Comparable as a comprehensive cancer research and clinical organization, though substantially larger and with a national/international patient draw.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights8 records

Customer concentration

• Xx.com/UFHealthCancer
• Facebookfacebook.com/ufhealthcancercenter
• LinkedInlinkedin.com/company/ufhcc
• Instagraminstagram.com/ufhealthcancer

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UF Health Cancer Center